T. Rowe Price Associates’s Leap Therapeutics LPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-119,200
| Closed | -$495K | – | 2967 |
|
|
2023
Q4 | $495K | Sell |
119,200
-325,000
| -73% | -$1.35M | ﹤0.01% | 2173 |
|
|
2023
Q3 | $613K | Sell |
444,200
-412,259
| -48% | -$569K | ﹤0.01% | 2012 |
|
|
2023
Q2 | $2.68M | Buy |
856,459
+702,736
| +457% | +$2.2M | ﹤0.01% | 1373 |
|
|
2023
Q1 | $523K | Buy |
+153,723
| New | +$523K | ﹤0.01% | 2084 |
|